RenovoRx, Inc. (RNXT) Gross margin 2024–2025
RenovoRx, Inc. (RNXT) gross margin by fiscal year — reported gross profit divided by reported revenue.
70.9%FY2025 · since FY2024: 100.0% → 70.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 70.9% | -29.1 pp |
| FY2024 | 100.0% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice